Start With the Patient, Not the A1C: What Happens When Visits Ask “What Matters Most?”

What if every diabetes appointment began with a simple question: “What matters most to you today?” Person-centered diabetes care encourages clinicians to look beyond A1C results and understand the challenges patients face in everyday life. However, does giving patients more control over their appointments actually improve outcomes? The QBSafe randomized clinical trial explored this question. Its findings offer important lessons about patient priorities, medication adherence, and the limits of conversation tools in diabetes management.

Table of Contents

1. Why Patient Priorities Matter in Diabetes Care
2. What the QBSafe Clinical Trial Revealed
3. Why Better Conversations May Not Improve A1C
4. Turning Patient Priorities Into Effective Diabetes Care
5. Conclusion
6. Frequently Asked Questions

Why Patient Priorities Matter in Diabetes Care

Traditional diabetes appointments often begin with laboratory results, glucose readings, and medication reviews. Although these measures are essential, they rarely capture the full experience of living with type 2 diabetes.

For example, a patient may have an A1C of 9% but struggle to afford medications or maintain regular meals. Another person might experience medication side effects that interfere with work or family responsibilities. Consequently, recommending additional treatment without addressing these challenges may create an unrealistic care plan.

This patient-focused approach helps clinicians align treatment decisions with each person's goals, preferences, and daily circumstances. Instead of focusing solely on glucose control, healthcare professionals consider what patients can realistically manage.

The American Diabetes Association's Standards of Care emphasize shared decision-making, individualized treatment, and the importance of considering factors that affect diabetes self-management. These recommendations recognize that successful diabetes management requires more than prescribing effective medications.

Furthermore, patient priorities may reveal barriers that routine clinical questions overlook. Financial stress, transportation difficulties, food insecurity, and treatment fatigue can all influence a person's ability to follow a treatment plan.

For healthcare professionals, understanding these concerns is an important part of developing practical care strategies. Readers can explore additional clinical discussions and diabetes management resources through Diabetes in Control.

Nevertheless, improving conversations does not automatically mean improving clinical outcomes. That distinction became central to the QBSafe trial.

What the QBSafe Clinical Trial Revealed

Published in October 2026 in JAMA Network Open, the QBSafe cluster-randomized clinical trial evaluated whether a structured conversation tool could improve diabetes care.

Researchers enrolled 143 adults with type 2 diabetes and A1C levels above 8%, along with 11 clinicians at a federally qualified health center in Connecticut. Participants received either usual primary care or usual care supplemented with an agenda-setting kit.

The intervention included 14 conversation cards covering concerns related to diabetes and its treatment. Before appointments, patients selected up to three cards identifying topics they wanted to discuss.

Clinicians then addressed those priorities early in the visit. Importantly, the intervention was designed to fit into routine appointments rather than require extensive additional counseling or major changes to clinical workflows.

QBSafe Results: A1C, Adherence, and Satisfaction

At six months, researchers found no statistically significant improvements in A1C, illness intrusiveness, treatment burden, or diabetes distress compared with usual care.

The adjusted between-group difference in A1C was -0.2 percentage points, with a 95% confidence interval ranging from -0.9 to 0.5. Therefore, the trial did not establish better glycemic control from the intervention.

However, medication adherence showed a more encouraging pattern. Average medication coverage reached 77.2% in the intervention group compared with 64.6% among controls.

Clinicians also reported greater satisfaction with appointments. Specifically, 62.2% of intervention-group visit ratings strongly agreed that the clinician was satisfied with the encounter, compared with 19.1% in the control group.

Patient satisfaction remained high in both groups, without a statistically significant difference. Interestingly, visit duration was also similar between groups, averaging approximately 23 minutes.

These findings suggest that structured discussions may improve aspects of the clinical encounter without substantially extending appointments. However, better communication and adherence did not produce a measurable advantage in A1C during the study period.

Why Better Conversations May Not Improve A1C

The QBSafe findings highlight an important challenge: identifying patient problems is not the same as solving them.

A patient may explain that medication costs are overwhelming. However, recognizing that concern does not automatically provide affordable treatment alternatives.

Similarly, discussing food insecurity cannot eliminate limited access to nutritious meals. Clinicians need practical resources and coordinated support to address these barriers.

These findings highlight why truly individualized diabetes care requires more than effective communication. A productive conversation should also help patients and clinicians develop realistic strategies for managing treatment challenges.

Although the conversation cards encouraged patients to express their priorities, the intervention provided limited additional support for resolving complex problems. As a result, identifying a concern did not always lead to a practical solution.

Furthermore, six months may not capture every potential benefit of improved communication. Changes in glucose control can depend on treatment adjustments, sustained medication access, and long-term self-management behaviors.

The trial also involved a single health center and a relatively small number of clinicians. Therefore, its findings may not apply equally across different healthcare settings or patient populations.

Importantly, the results do not suggest that patient-centered conversations are unnecessary. Rather, they show that an agenda-setting tool alone did not significantly improve the trial's primary outcomes.

Better medication adherence and greater clinician satisfaction remain noteworthy findings. Nevertheless, larger studies are needed to determine whether these benefits can be sustained and translated into better long-term health outcomes.

Turning Patient Priorities Into Effective Diabetes Care

For healthcare professionals, the QBSafe study offers a practical lesson: conversations should lead to meaningful action.

Clinicians can begin appointments by asking patients which diabetes-related challenge deserves immediate attention. Next, they can explore how that concern affects medication use, glucose monitoring, nutrition, or daily activities.

For instance, someone struggling with multiple daily injections may benefit from discussing a simpler treatment schedule when clinically appropriate. Another patient may need help understanding medication costs, insurance coverage, or available assistance programs.

Likewise, patients prescribed medications such as Ozempic (semaglutide), Jardiance (empagliflozin), or insulin may have concerns about cost, side effects, or treatment complexity.

However, treatment changes should reflect individual clinical needs, safety considerations, and patient preferences rather than convenience alone.

A practical approach also involves documenting patient priorities and revisiting them during follow-up visits. This helps ensure that important concerns do not disappear once the appointment ends.

In addition, diabetes educators, pharmacists, social workers, and care coordinators can help address barriers that clinicians cannot resolve during a single consultation.

Shared decision-making may also improve when healthcare professionals explain treatment options in plain language and invite patients to describe what they believe is manageable.

Ultimately, successful diabetes management requires both sound clinical decisions and realistic strategies patients can follow. The goal is not simply to make patients feel heard, but to help them participate in treatment decisions that fit their lives.

Individuals seeking personalized medical guidance can also explore Healthcare.pro for information about connecting with healthcare professionals.

Conclusion

The QBSafe trial offers valuable insight into the benefits and limitations of putting patients at the center of diabetes treatment. Asking what matters most may help clinicians understand treatment challenges and support medication adherence. Nevertheless, the intervention did not significantly improve A1C, diabetes distress, or treatment burden at six months.

The central lesson is straightforward: listening is essential, but listening alone is insufficient.

Healthcare teams must connect patient priorities with practical solutions, ongoing support, and individualized treatment decisions. When conversations lead to meaningful changes, diabetes care has a better opportunity to fit patients' lives.

Frequently Asked Questions

1. What does person-centered diabetes care mean?

It means developing diabetes treatment plans around each patient's medical needs, personal goals, preferences, and everyday challenges. This approach combines evidence-based treatment with shared decision-making.

2. Did the QBSafe trial improve A1C levels?

No. Although A1C improved in both study groups, researchers found no statistically significant difference between the intervention and usual-care groups after six months.

3. Did QBSafe improve medication adherence?

Yes. Pharmacy-based medication coverage was higher in the intervention group. However, this finding did not translate into a statistically significant A1C improvement during the study.

4. Why is shared decision-making important in diabetes management?

Shared decision-making helps clinicians select treatments that reflect patients' preferences, health needs, and circumstances. Consequently, care plans may become more practical and easier to maintain over time.

5. What should clinicians learn from the QBSafe findings?

Structured conversations can uncover important patient concerns, but additional resources may be needed to address them. Effective diabetes management should combine patient engagement, evidence-based treatment, and coordinated follow-up.

Disclaimer: This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.